Skip to main content

Applications of next-generation sequencing in hematological neoplasms

From the 2021 Joint Annual Meeting (recorded 6/28/2021)
Presented by Cinthya J Zepeda Mendoza, Ph.D.

Next-generation sequencing (NGS) has revolutionized the study of hematological neoplasms, by quickly becoming a routine clinical testing methodology for diagnostic, prognostic, and follow-up of patients. This session will introduce the applications of NGS for the detection of clinically relevant genetic abnormalities in hematological neoplasms, ranging from detection of single nucleotide variants to large structural rearrangements, as well as their impact in patient management and treatment.

At the conclusion of this presentation, participants will be able to:

  • Recognize the multiple application levels of NGS in the study of hematological neoplasms
  • Identify NGS improvement opportunities through interaction with a practicing medical director
  • Discuss the different challenges that NGS testing implementation entail in a clinical laboratory

ASCLS is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the area of General (Molecular Pathology) will be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of Certification and all states, including Florida and California, as an approved provider of continuing education for recertification and licensure. ASCLS is an approved provider with CE Broker for Florida licensees.
This Intermediate-level program is appropriate for laboratory professionals working in clinical, public health and academic settings.